Canaccord Genuity Maintains Buy on Clene, Lowers Price Target to $86
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity has maintained its Buy rating on Clene (NASDAQ:CLNN) but lowered the price target from $94 to $86.

October 04, 2024 | 2:44 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Canaccord Genuity has maintained its Buy rating on Clene but reduced the price target from $94 to $86, indicating a positive outlook with some caution.
The maintenance of a Buy rating suggests continued confidence in Clene's potential, but the lowered price target indicates some caution or adjustment in expectations. This mixed signal may result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100